A股異動丨中廣核技逼近漲停 提供高質量電子束輻照滅菌服務
格隆匯2月10日丨中廣核技(000811.SZ)逼近漲停,報7.26元,總市值68.6億元。自新型冠狀病毒感染的肺炎疫情發生後,截至2月6日晚,公司已經先後為22個相關單位,累計53批,超過200萬件(片/副/套)醫療物資提供了滅菌服務。其中,包括一次性口罩、醫用檢測棉籤、醫用手套、標本採集器、採血針、防護服、醫用泵頭、檢驗杯、測序試劑盒大槽、無紡帽、試劑容器等醫療物資。據悉,自疫情發生以來,中廣核技在旗下中廣核達勝(江蘇蘇州)、南通海維(江蘇南通)、山東海維(山東乳山)、中廣核戈瑞(廣東深圳)等各個輻照消毒滅菌中心,開通綠色通道,24小時待命,運用電子加速器技術,持續為戰“疫”前線急需緊缺醫療物資提供免費、快速、及時、高質量的電子束輻照滅菌服務。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.